Your browser doesn't support javascript.
loading
Sustainable return to work among breast cancer survivors.
Ruiz de Azua, Garazi; Kousignian, Isabelle; Vaz-Luis, Ines; Di Meglio, Antonio; Caumette, Elsa; Havas, Julie; Martin, Elise; Martin, Anne-Laure; Querel, Ophelie; Vanlemmens, Laurence; Pistilli, Barbara; Coutant, Charles; Cottu, Paul Henri; Merimeche, Asma Dhaini; Lerebours, Florence; Tredan, Olivier; Jouannaud, Christelle; Levy, Christelle; Dumas, Agnes; Menvielle, Gwenn.
Afiliación
  • Ruiz de Azua G; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.
  • Kousignian I; Université Paris Cité, Unité de Recherche «Biostatistique, Traitement et Modélisation des données bio-logiques¼ BioSTM, UR 7537, Paris, France.
  • Vaz-Luis I; Medical Oncology Department, Gustave Roussy, Villejuif, France.
  • Di Meglio A; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Caumette E; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Havas J; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Équipe de Recherche en Épidémiologie Sociale, Paris, France.
  • Martin E; Department of Maieutics, Université de Montpellier, Montpellier, France.
  • Martin AL; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Querel O; INSERM Unit 981-Prédicteurs moléculaires et nouvelles cibles en oncologie, Gustave Roussy, Villejuif, France.
  • Vanlemmens L; UCBG, UNICANCER, Paris, France.
  • Pistilli B; UCBG, UNICANCER, Paris, France.
  • Coutant C; Centre Oscar Lambret, Lille, France.
  • Cottu PH; Breast Cancer Group, Institut Gustave-Roussy, Villejuif, France.
  • Merimeche AD; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Lerebours F; Department of Medical Oncology, Institut Curie, Paris, France.
  • Tredan O; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France.
  • Jouannaud C; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
  • Levy C; Centre Léon Berard, Lyon, France.
  • Dumas A; Institut Jean Godinot Reims, Reims, France.
  • Menvielle G; Centre François Baclesse, Caen, France.
Cancer Med ; 12(18): 19091-19101, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37602836
ABSTRACT

PURPOSE:

This study assessed sustainable return to work (SRTW) of breast cancer survivors (BCS).

METHODS:

We used data from the prospective French cohort, CANTO. We included 1811 stage I-III BCS who were <57 years old and employed at the moment of diagnosis and working 2 years after diagnosis. Using logistic regression, we investigated the role of clinical, health and socio-economic factors, and the work environment on SRTW 3 years after diagnosis. We compared having any sick leave with having worked continuously and being unemployed to having worked continuously between 2 and 3 years after diagnosis.

RESULTS:

Overall, 77% (n = 1395) worked continuously after return to work (RTW). Out of the other 416 BCS, 66% had any sick leave period, 33% had been unemployed, 4% had an early retirement, 2% a disability and 1% another status (multiple situations possible). Being on sick leave was associated with age > 50 (OR = 0.59; 95%CI = 0.43-0.82), stage III (2.56; 1.70-3.85), tumour subtype HR+/HER2+ (0.61; 0.39-0.95), severe fatigue (1.45; 1.06-1.98), workplace accommodations (1.63; 1.14-2.33) and life priorities (0.71; 0.53-0.95). Unemployment was associated with age > 50 (0.45; 0.29-0.72), working in the public sector (0.31; 0.19-0.51), for a small company (3.00; 1.74-5.20) and having a fixed-term contract (7.50; 4.74-11.86).

CONCLUSIONS:

A high number of BCS have periods of sick leave or unemployment after RTW. The determinants differ between sick leave and unemployment. IMPLICATIONS FOR CANCER SURVIVORS BCS need to be supported even after RTW, which should be regarded as a process.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Francia